What does CUSIP 77313F106 represent in this 13F holders report?

CUSIP 77313F106 is the security identifier for RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in Q2 2018?

75 institutional investors reported RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)

CUSIP: 77313F106

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 109,265,652
Total 13F shares: 31,064,522
Share change: +3,211,194
Total reported value: $605,382,076
Put/Call ratio: 0%
Price per share: $19.63
Number of holders: 75
Value change: +$63,867,898
Number of buys: 51
Number of sells: 27

Quarterly Holders Quick Answers

What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 77313F106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RTW INVESTMENTS, LP	13F	Company	14%	14,969,744	$258,228,000	—	31 Mar 2018	13F
Boxer Capital, LLC	13F	Company	1.8%	1,966,051	$36,863,000	—	31 Mar 2018	13F
BRIDGER MANAGEMENT, LLC	13F	Company	1.4%	1,578,569	$29,598,000	—	31 Mar 2018	13F
Cormorant Asset Management, LP	13F	Company	1.4%	1,519,891	$28,498,000	—	31 Mar 2018	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.92%	1,000,000	$18,750,000	—	31 Mar 2018	13F
Ghost Tree Capital, LLC	13F	Company	0.78%	850,000	$15,938,000	—	31 Mar 2018	13F
ORBIMED ADVISORS LLC	13F	Company	0.71%	775,000	$14,531,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.62%	674,019	$12,637,000	—	31 Mar 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.44%	485,005	$9,094,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.38%	419,502	$7,866,000	—	31 Mar 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.37%	400,000	$7,500,000	—	31 Mar 2018	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.36%	394,585	$7,398,000	—	31 Mar 2018	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.32%	350,000	$6,563,000	—	31 Mar 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.28%	302,275	$5,668,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	0.23%	250,000	$4,688,000	—	31 Mar 2018	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.23%	250,000	$4,688,000	—	31 Mar 2018	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.2%	216,158	$4,053,000	—	31 Mar 2018	13F
ASCEND CAPITAL, LLC	13F	Company	0.18%	199,947	$3,748,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.15%	167,675	$3,144,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.13%	139,200	$2,610,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.12%	134,560	$2,523,000	—	31 Mar 2018	13F
Iguana Healthcare Management, LLC	13F	Company	0.11%	125,000	$2,344,000	—	31 Mar 2018	13F
A.R.T. Advisors, LLC	13F	Company	0.09%	98,544	$1,847,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	0.08%	83,562	$1,567,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.07%	80,478	$1,508,000	—	31 Mar 2018	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.07%	71,459	$1,340,000	—	31 Mar 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.05%	59,456	$1,115,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.05%	55,506	$1,041,000	—	31 Mar 2018	13F
Tibra Equities Europe Ltd	13F	Company	0.04%	47,198	$885,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.04%	46,381	$870,000	—	31 Mar 2018	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.04%	45,298	$849,000	—	31 Mar 2018	13F
BARCLAYS PLC	13F	Company	0.03%	36,100	$677,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.03%	33,098	$620,000	—	31 Mar 2018	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	24,460	$459,000	—	31 Mar 2018	13F
TD ASSET MANAGEMENT INC	13F	Company	0.02%	20,195	$379,000	—	31 Mar 2018	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.02%	19,032	$357,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.02%	18,272	$343,000	—	31 Mar 2018	13F
ARDSLEY ADVISORY PARTNERS LP	13F	Company	0.01%	15,000	$281,000	—	31 Mar 2018	13F
Monarch Partners Asset Management LLC	13F	Company	0.01%	14,982	$281,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.01%	11,096	$208,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	7,673	$144,000	—	31 Mar 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	6,968	$130,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0%	4,111	$76,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0%	3,151	$59,000	—	31 Mar 2018	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	2.7%	2,965,485	$55,603	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0%	2,394	$45,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0%	1,568	$29,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0%	1,086	$20,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	652	$12,000	—	31 Mar 2018	13F
Cable Hill Partners, LLC	13F	Company	0%	500	$7,000	—	31 Mar 2018	13F

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q2 2018

As of 30 Jun 2018, ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by 75 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,064,522 shares. The largest 10 holders included RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, BRIDGER MANAGEMENT, LLC, Cormorant Asset Management, LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, CITADEL ADVISORS LLC, ORBIMED ADVISORS LLC, and DEUTSCHE BANK AG\. This page lists 75 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.